OVAT Stock Overview
Ovation Science Inc. engages in the production, sub-licensing and sales of cannabis or hemp products in Canada, the United States, and Mexico.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Ovation Science Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.055 |
| 52 Week High | CA$0.06 |
| 52 Week Low | CA$0.01 |
| Beta | 0.11 |
| 1 Month Change | 10.00% |
| 3 Month Change | n/a |
| 1 Year Change | 266.67% |
| 3 Year Change | -72.50% |
| 5 Year Change | -90.00% |
| Change since IPO | -87.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| OVAT | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -3.6% | 0.7% |
| 1Y | 266.7% | 54.7% | 5.5% |
Return vs Industry: OVAT exceeded the Canadian Pharmaceuticals industry which returned 53% over the past year.
Return vs Market: OVAT exceeded the Canadian Market which returned 6.1% over the past year.
Price Volatility
| OVAT volatility | |
|---|---|
| OVAT Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 13.8% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.2% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: OVAT's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine OVAT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | Terry Howlett | ovationscience.com |
Ovation Science Inc. engages in the production, sub-licensing and sales of cannabis or hemp products in Canada, the United States, and Mexico. The company’s Invisicare is a patented drug delivery technology for use in topical and transdermal cannabis products under the Ovation. It offers recreation transdermal cream under the BASKiN names; cannabidiol health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and hand sanitizers under the DermSafe name.
Ovation Science Inc. Fundamentals Summary
| OVAT fundamental statistics | |
|---|---|
| Market cap | CA$1.94m |
| Earnings (TTM) | -CA$793.99k |
| Revenue (TTM) | CA$82.69k |
23.4x
P/S Ratio-2.4x
P/E RatioIs OVAT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OVAT income statement (TTM) | |
|---|---|
| Revenue | CA$82.69k |
| Cost of Revenue | CA$2.87k |
| Gross Profit | CA$79.82k |
| Other Expenses | CA$873.81k |
| Earnings | -CA$793.99k |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.023 |
| Gross Margin | 96.52% |
| Net Profit Margin | -960.18% |
| Debt/Equity Ratio | -26.2% |
How did OVAT perform over the long term?
See historical performance and comparison